Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E09, Qapzola™) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder Cancer.
Journal Information
Full Title: Bladder Cancer
Abbreviation: Bladder Cancer
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Financial disclosures: Gajanan Bhat, Guru Reddy, and Szu-Yun Leu are employees of Spectrum Pharmaceuticals; Alfred Witjes, Lawrence Karsh, and Neal Shore are advisors to Spectrum Pharmaceuticals."
Funding Disclosure
Evidence found in paper:
"FUNDING/SUPPORT AND ROLE OF THE SPONSOR"
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025